home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Mediator Of Multiple Sclerosis

  August, 27 2009 19:20
your information resource in human molecular genetics

A factor that may contribute to the progressive phase of multiple sclerosis (MS) has been identified in a paper published online in Nature Immunology.

Multiple sclerosis is an autoimmune disease that affects a person's nervous system and leads to physical and cognitive disabilities. There are different patterns of progression for MS with the irreversible progressive phase appearing after the relapsing-remitting phase of the disease. There is currently no effective therapy for the progressive phase of MS.

A group led by Howard Weiner and Francisco Quintana identified a lipid, 15-HC, that is present in elevated concentrations in patients with progressive, but not relapsing-remitting, MS. The scientists found that 15-HC activates a receptor called PARP-1 and that inhibition of PARP-1 activity slows the progression of MS in a mouse model of MS.

Future work will determine whether PARP-1 activity can be manipulated for therapeutic benefit in patients with progressive MS.

Author contacts:

Howard Weiner (Brigham and Women's Hospital, Boston, MA, USA)
E-mail: hweiner@rics.bwh.harvard.edu

Francisco Quintana (Brigham and Women's Hospital, Boston, MA, USA)
E-mail: fquintana@rics.bwh.harvard.edu

Abstract available online.

(C) Nature Immunology.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.